Two Hot Stocks Under Limelight: Vipshop Holdings Limited (NYSE:VIPS) ; Viking Therapeutics, Inc. (NASDAQ:VKTX)

Vipshop Holdings Limited (NYSE:VIPS)

Vipshop Holdings Limited (NYSE:VIPS) closed at $5.93 on the last trading session with an decrease of -3.73%, whereas, it previously closed at $6.16. The company has a market capitalization of $3.78 Billion. The company traded shares of 8.35 Million on the trading day while its three month average volume stands at 6.9 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Vipshop Holdings Limited (NYSE:VIPS) produced diluted EPS of 0.46. The EPS estimate for next year as estimated by analysts is at 0.64 while EPS for next quarter is estimated at 0.17. Earnings per Share growth for this year is reported at -4.2, while the analysts estimated the EPS growth for next year at 0.64% and Earnings growth for next 5 years stands at 0.14% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 171.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Vipshop Holdings Limited (NYSE:VIPS) is at 13 while the forward p/e is at 9.27. The P/S or Price to Sales ratio of Vipshop Holdings Limited (NYSE:VIPS) stands at 0.31 and Price to Book or P/B for the most recent quarter stands at 1.64. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Vipshop Holdings Limited (NYSE:VIPS) are reported at 0.9 and 1.1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Vipshop Holdings Limited (NYSE:VIPS) stands at 5.8, 13.6 and 7 respectively

The trailing twelve month Revenue of Vipshop Holdings Limited (NYSE:VIPS) is reported at 12.02 Billion with income of 307.6 Million. The outstanding shares of Vipshop Holdings Limited (NYSE:VIPS) are 637.25 Million. The institutional Ownership of the shares of 59.5 stands at 0.80%, this figure is decreased -0.23 in the last six months. The insider ownership for the shares of Vipshop Holdings Limited (NYSE:VIPS) is ticked at 5.28%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Vipshop Holdings Limited (NYSE:VIPS) is the Mean Target Price estimated by the analysts which stands at 7.46. The 52 week high of Vipshop Holdings Limited (NYSE:VIPS) is placed at 19.14 and 52 week low is standing at 4.30.

Performance wise the shares of Vipshop Holdings Limited (NYSE:VIPS) rose up 12.31% for the week, it also rise 11.89% for the monthly performance, while for the quarter it went down 11.05%. The shares decrease -42.71% for the half year and flew up for the Year-To-Date performance. The shares of Vipshop Holdings Limited (NYSE:VIPS) shrinked -55.18% for the yearly performance.

Viking Therapeutics, Inc. (NASDAQ:VKTX)

Viking Therapeutics, Inc. (NASDAQ:VKTX) closed at $8.23 on the last trading session with an decrease of -2.14%, whereas, it previously closed at $8.41. The company has a market capitalization of $593.05 Million. The company traded shares of 2.55 Million on the trading day while its three month average volume stands at 3.27 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) produced diluted EPS of -0.45. The EPS estimate for next year as estimated by analysts is at -0.48 while EPS for next quarter is estimated at -0.1. Earnings per Share growth for this year is reported at 12.5, while the analysts estimated the EPS growth for next year at -0.48% and Earnings growth for next 5 years stands at 40% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Viking Therapeutics, Inc. (NASDAQ:VKTX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Viking Therapeutics, Inc. (NASDAQ:VKTX) stands at 0 and Price to Book or P/B for the most recent quarter stands at 1.67. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Viking Therapeutics, Inc. (NASDAQ:VKTX) are reported at 64.6 and 64.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Viking Therapeutics, Inc. (NASDAQ:VKTX) stands at -15.1, -15.8 and 0 respectively

The trailing twelve month Revenue of Viking Therapeutics, Inc. (NASDAQ:VKTX) is reported at 0 with income of -20900000. The outstanding shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) are 72.06 Million. The institutional Ownership of the shares of 62 stands at 0.80%, this figure is increased 0.21 in the last six months. The insider ownership for the shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) is ticked at 8.5%, the figure is plummeted -4.12% in the last six months.

Some other important financial aspects to be discussed here for Viking Therapeutics, Inc. (NASDAQ:VKTX) is the Mean Target Price estimated by the analysts which stands at 29.79. The 52 week high of Viking Therapeutics, Inc. (NASDAQ:VKTX) is placed at 24.00 and 52 week low is standing at 3.69.

Performance wise the shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) rose up 8.58% for the week, it also fell -13% for the monthly performance, while for the quarter it went up -43.51%. The shares decrease -17.7% for the half year and flew up for the Year-To-Date performance. The shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) grew 60.74% for the yearly performance.